BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 11217436)

  • 1. [Analysis of clonality of nephroblastomas in patients with Wilms tumors].
    Gürtl B; Ratschek M; Harms D; Jänig U; Böcker W; Poremba C; Höfler G
    Verh Dtsch Ges Pathol; 2000; 84():162-3. PubMed ID: 11217436
    [No Abstract]   [Full Text] [Related]  

  • 2. Clonality and loss of heterozygosity of WT genes are early events in the pathogenesis of nephroblastomas.
    Guertl B; Ratschek M; Harms D; Jaenig U; Leuschner I; Poremba C; Hoefler G
    Hum Pathol; 2003 Mar; 34(3):278-81. PubMed ID: 12673563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased E-cadherin expression correlates with higher stage of Wilms' tumors.
    Safford SD; Freemerman AJ; Langdon S; Bentley R; Goyeau D; Grundy PE; Skinner MA
    J Pediatr Surg; 2005 Feb; 40(2):341-8. PubMed ID: 15750927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Problems of histogenesis and classification of nephroblastoma (Wilms' tumor) in children].
    Sukhova VN
    Arkh Patol; 1977 Jan; 39(1):32-8. PubMed ID: 190982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Wilms' tumor: current classification and the basic principles of a morphological study].
    Muianich GM; Popov SD; Popova ED
    Arkh Patol; 2006; 68(6):46-9. PubMed ID: 17290897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low frequency of EWSR1 rearrangements in neoplasms classified as high-risk Wilms tumors.
    Frigyesi I; Möller E; Stewénius Y; Isaksson M; Bras J; Alumets J; Øra I; Sandstedt B; Gisselsson D
    Pediatr Blood Cancer; 2009 Oct; 53(4):683-4. PubMed ID: 19492315
    [No Abstract]   [Full Text] [Related]  

  • 7. Genetic clonality is a feature unifying nephroblastomas regardless of the variety of morphological subtypes.
    Guertl B; Leuschner I; Harms D; Hoefler G
    Virchows Arch; 2006 Aug; 449(2):171-4. PubMed ID: 16715229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two candidate tumor suppressor genes, MEOX2 and SOSTDC1, identified in a 7p21 homozygous deletion region in a Wilms tumor.
    Ohshima J; Haruta M; Arai Y; Kasai F; Fujiwara Y; Ariga T; Okita H; Fukuzawa M; Hata J; Horie H; Kaneko Y
    Genes Chromosomes Cancer; 2009 Dec; 48(12):1037-50. PubMed ID: 19760604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heritable fraction of unilateral Wilms tumor.
    Li FP; Williams WR; Gimbrere K; Flamant F; Green DM; Meadows AT
    Pediatrics; 1988 Jan; 81(1):147-9. PubMed ID: 2827098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wilms tumors develop through two distinct karyotypic pathways.
    Höglund M; Gisselsson D; Hansen GB; Mitelman F
    Cancer Genet Cytogenet; 2004 Apr; 150(1):9-15. PubMed ID: 15041217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pathology of renal tumors].
    Eder M
    Fortschr Geb Rontgenstr Nuklearmed; 1972; ():Suppl:35. PubMed ID: 4344574
    [No Abstract]   [Full Text] [Related]  

  • 12. Multiple pathways to Wilms tumor: how much is genetic?
    Pritchard-Jones K; Vujanic G
    Pediatr Blood Cancer; 2006 Sep; 47(3):232-4. PubMed ID: 16830319
    [No Abstract]   [Full Text] [Related]  

  • 13. Epithelial differentiation in Wilms' tumor: a clinicopathologic appraisal.
    Chatten J
    Perspect Pediatr Pathol; 1976; 3():225-54. PubMed ID: 184430
    [No Abstract]   [Full Text] [Related]  

  • 14. Suggested change in definitional criteria for stage 1 Wilms tumor treated by surgery only.
    Beckwith JB
    Pediatr Blood Cancer; 2011 Jan; 56(1):168; author reply 169-70. PubMed ID: 21108447
    [No Abstract]   [Full Text] [Related]  

  • 15. The management and biological behavior of Wilms tumor.
    Coopes MJ
    Int Rev Exp Pathol; 1994; 35():149-76. PubMed ID: 7860189
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical relevance of mutations in the Wilms tumor suppressor 1 gene WT1 and the cadherin-associated protein beta1 gene CTNNB1 for patients with Wilms tumors: results of long-term surveillance of 71 patients from International Society of Pediatric Oncology Study 9/Society for Pediatric Oncology.
    Royer-Pokora B; Weirich A; Schumacher V; Uschkereit C; Beier M; Leuschner I; Graf N; Autschbach F; Schneider D; von Harrach M
    Cancer; 2008 Sep; 113(5):1080-9. PubMed ID: 18618575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene expression profiling of favorable histology Wilms tumors and its correlation with clinical features.
    Takahashi M; Yang XJ; Lavery TT; Furge KA; Williams BO; Tretiakova M; Montag A; Vogelzang NJ; Re GG; Garvin AJ; Söderhäll S; Kagawa S; Hazel-Martin D; Nordenskjold A; Teh BT
    Cancer Res; 2002 Nov; 62(22):6598-605. PubMed ID: 12438255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Review and classification of metanephric neoplasms in childhood].
    Stambolis C; Alles J; Jundt G; Hatzibujas J; Gabrielides KG
    Pathologe; 1982 Mar; 3(2):77-84. PubMed ID: 6283518
    [No Abstract]   [Full Text] [Related]  

  • 19. All-trans retinoic acid treatment of Wilms tumor cells reverses expression of genes associated with high risk and relapse in vivo.
    Zirn B; Samans B; Spangenberg C; Graf N; Eilers M; Gessler M
    Oncogene; 2005 Aug; 24(33):5246-51. PubMed ID: 15897880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of apoptosis, cell proliferation, and drug resistance genes in pediatric Wilms' tumors.
    Ramachandran C; Melnick SJ; Escalon E; Jhabvala P; Khatib Z; Alamo A; Smith S
    Anticancer Res; 2000; 20(5C):3759-65. PubMed ID: 11268451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.